Biohaven Pharmaceuticals, Inc.
Clinical trials sponsored by Biohaven Pharmaceuticals, Inc., explained in plain language.
-
New Muscle-Boosting drug enters final testing for debilitating nerve disease
Disease control OngoingThis study is testing whether a new drug called taldefgrobep alfa can improve muscle strength and function in people with spinal muscular atrophy (SMA). The drug is designed to block a protein that limits muscle growth. Participants will be people already receiving standard SMA t…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 04, 2026 07:50 UTC
-
New drug trial aims to slow progression of rare movement disorder
Disease control OngoingThis study is testing whether a daily medication called troriluzole can help slow the worsening of movement, balance, and speech problems in adults with inherited spinocerebellar ataxia (SCA). About 300 participants with specific types of SCA will take either troriluzole or a pla…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC